Jeremie Heath Estepp MD

PubMed

• A Novel One-Sample Mendelian Randomization Approach for Count-Type Outcomes That Is Robust to Correlated and Uncorrelated Pleiotropic Effects.
  Janaka S S Liyanage, Jane S Hankins, Jeremie H Estepp, Deokumar Srivastava, Sara R Rashkin
  Genetic Epidemiology. 2025-01-01
• 1 citations
  Social determinants of health affect disease severity among preschool children with sickle cell disease.
  Hamda Khan, Guolian Kang, Jerlym S Porter, Juan Ding, Winfred C Wang
  Blood Advances. 2024-12-10
• Changes in indicators of cerebral metabolic stress following treatment with voxelotor in children and adolescents with sickle cell anemia.
  Andrew M Heitzer, Ping Zou, Jason Hodges, Clark Brown, Mark Davis
  Ejhaem. 2024-10-01

Journal Articles

• A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy  
  Estepp JH, Smeltzer MP, Kang G, Aygun B, Abrams C, Wang W, Ware RE, Nottage K, Hankins J, American Journal of Hematology, 1/1/2017

Books/Book Chapters

• The Eye in Pediatric Systemic Disease 
  Chapter: Hematologic disorders of the eye. 
  Hoehn ME, Elder JE and Estepp JHSpringer International Publishing, New York, NYEdition 1st,2017
• Keeling's Fetal and Neonatal Pathology 
  Chapter: Perinatal Hematology 
  Choi JK and Estepp JHSpringer International Publishing, New York, NYEdition 5th,2016
• Sickle Cell Anemia: From Basic Science to Clinical Practice 
  Chapter: Future Perspectives for the Treatment of Sickle Cell Disease. 
  Nottage KA, Estepp JH, Hankins JSSpringer International Publishing, New York, NY2016

Abstracts/Posters

• Disease Modeling and Phenotype Rescue Using Inducible Pluripotent Stem Cells from Patients with Diamond-Blackfan Anemia
  Jeremie H. Estepp, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Phase 1 Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of FT-4202, an Allosteric A...
  Jeremy H. Estepp, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Progression of Central Nervous System Vasculopathy in Young Adults with Sickle Cell Anemia
  Jeremie H. Estepp, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Trends in Hospitalization Rates in a Prospective Cohort of Pediatric Sickle Cell Disease Patients on Hydroxyurea Therapy.
  Meadows MB; Smeltzer MP; Hankins J; Estepp JH, 2017 Annual Meeting of the American College of Epidemiology, New Orleans, LA, 1/1/2017
• The Pharmacokinetics (PK) of GBT440 are Similar in Adolescents and Adults with Sickle Cell Disease (SCD).
  Washington C; Savic R, Inati A; Estepp JH; Woods G; Fong E; Hutchaleelaha A; Tonda M; Balaratnam G; Lehrer-Graiwer J, 22nd Congress of the European Hematology Association, Madrid, Spain, 1/1/2017
• Neurocognitive Functioning in Preschool Children with Sickle Cell Disease.
  Schreiber JE, Ali JS, Jurbergs N, Ehrentraut JH, Estepp JH, Boggs J, Aygun B, Wang WC, Annual Society of Pediatric Psychology Meeting, Portland, OR, 1/1/2017
• Cognitive function in preschool-aged children with sickle cell disease: associations with home environment and disease-severity.
  Schreiber JE, Beaulieu R, White L, Hall L, Estepp JH, Wang WC, 45th Annual Meeting: International Neuropsychological Society, New Orleans, LA, 1/1/2017
• Whole Genome Sequence Analysis of Fetal Hemoglobin in African American Sickle Cell Patients.
  Rampersaud E, Kang G, Yasui Y, Wang S, Feng R, Estepp JH, Zhang J, Hankins J, Wu G, Weiss M, 13th Annual Meeting: International Congress of Human Genetics, Kyoto, Japan, 1/1/2016
• Re-Aiming at Hydroxyurea Adherence for Sickle Cell with mHealth (Re-HASH).
  Hankins J, Gurney J, Porter J, Kang G, Carroll Y, Hodges J, Alberts N, Smeltzer M, Hamayouni R, DeBon M, Osarogiabon R, Cooper W, Debaun M, Estepp JH, Weiss M, Klesges L, Faculty/Postdoctoral Poster Research Day, St. Jude Children's Hospital, Memphis, TN, 1/1/2016
• Clinical and laboratory features of hemoglobin S/(A/gamma/delta/Beta)0-thalassemia.
  Cancio MI, Aygun B, Chui DH, Estepp JH, Smeltzer MP, Hankins JS, 58th Annual Meeting: American Society of Hematology, San Diego, CA, 1/1/2016
• Pharmacokinetics in children with sickle cell anemia following single dose versus chronic treatment with hydroxyurea.
  Mack MJ, Wiczling P, Moen J, Kang G, Liem RI, Panepinto JA, Kearns GK, Neville KA, Estepp JH, 58th Annual Meeting: American Society of Hematology, San Diego, CA, 1/1/2016
• Hydroxyurea at maximal tolerated dose (MTD) prior to completion of the Beta-globin switch has additive but not sustained benefits in fetal hemoglobin production.
  Abrams C, Moen J, Kang K, Wang WC, Hankins J, Estepp JH, 58th Annual Meeting: American Society of Hematology, San Diego, CA, 1/1/2016
• Neurocognitive Functioning Among Young Patients with Sickle Cell Disease: Associations with Demographic and Disease-Related Factors.
  Ali JS, Schreiber JE, Ehrentraut J, Jurbergs N, Estepp JH, Martin J, Aygun B, Wang WC, International Neuropsychological Society Annual Meeting, Boston, MA, 1/1/2016
• Prognostic Factors for Hospitalization of Children with Sickle Cell Anemia Treated with Hydroxyurea at Maximum Tolerated Dose.
  Estepp JH, Huan Q, Wang WC, Kang G, 57th Annual Meeting: American Society of Hematology, Orlando, FL, 1/1/2015
• Brigance Preschool Screen II and Neurocognitive Functioning Among Young Patients with Sickle Cell Disease.
  Ali JS, Schreiber JE, Ehrentraut J, Jurbergs N, Estepp JH, Martin J, Aygun B, Wang WC, Society for Developmental and Behavioral Pediatrics, Las Vegas, NV, 1/1/2015
• Escalating doses of hydroxyurea in very young children with sickle cell anemia.
  Estepp JH, Wang WC, 2th Annual Global Sickle Cell Anemia Congress, Rio de Janeiro, Brazil, 1/1/2014
• Improved adherence to hydroxyurea in children with sickle cell anemia utilizing text messages.
  Estepp JH, Johnson M, Smeltzer MP, Winter B, Carroll Y, Hankins JS, 2th Annual Global Sickle Cell Anemia Congress, Rio de Janeiro, Brazil, 1/1/2014
• Intensification of hydroxyurea therapy in young children with sickle cell anemia.
  Estepp JH, Smeltzer MP, Lian S, Kang GK, Wang WC, 8th Annual Sickle Cell Disease Research and Educational Symposium and 37th National Sickle Cell Disease Scientific Meeting, Miami, FL, 1/1/2014
• Escalating doses of hydroxyurea in very young children with sickle cell anemia.
  Lian S, Estepp JH, Wang WC, 55th Annual Meeting: American Society of Hematology, 1/1/2013
• Traumatic lumbar punctures in children receiving low-molecular-weight heparin during treatment for acute lymphoblastic leukemia or lymphoma.
  Estepp JH, Smeltzer MP, Howard SC, Reiss UM, Faculty/Postdoctoral Poster Research Day, St. Jude Children's Hospital, Memphis, TN, 1/1/2013
• Improved adherence to hydroxyurea in children with sickle cell anemia utilizing text messages.
  Estepp JH, Johnson M, Smeltzer MP, Winter B, Carroll Y, Hankins JS, 26th Annual Meeting: American Society of Pediatric Hematology and Oncology, Miami, FL, 1/1/2013
• Effect of "therapeutic" anticoagulation with low-molecular-weight-heparin on recurrent venous thrombosis in children.
  Estepp JH, Smeltzer M, Reiss UM, 4th Annual Pediatric Research Day, Memphis, TN, 1/1/2011
• Effect of "therapeutic" anticoagulation with low-molecular-weight-heparin on recurrent venous thrombosis in children.
  Estepp JH, Smeltzer M, Reiss UM, 24th Annual Meeting: American Society of Pediatric Hematology and Oncology, 1/1/2011
• The impact of hydroxyurea therapy on the prevalence of retinopathy in a pediatric sickle cell cohort.
  Estepp JH, Smeltzer M, Aygun B, 53rd Annual Meeting: American Society of Hematology, 1/1/2011
• Join now to see all

Lectures

• Transcranial Doppler Velocities Conversion Rate Based on Increasing Hemoglobin Concentration: Analysis from the SCCRIP Cohort Study 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Fetal Hemoglobin Level during Hydroxyurea Therapy Varies By Neighborhood 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Effects of Hydroxyurea on Neurocognitive Performance in Children with Sickle Cell Disease: A Prospective Trial. 
  Atlanta, GA - 1/1/2018
• "FDA Approved Disease Modifiers" 
  Washington University School of Medicine, St. Louis, MO - 1/15/2017
• Hydroxyurea at Maximal Tolerated Dose (MTD) Prior to Completion of the Beta-globin Switch Has Additive but Not Sustained Benefits in Fetal Hemoglobin Production. 
  San Diego, CA - 1/1/2017
• "Hydroxyurea Therapy in Sickle Cell Disease" 
  St. Jude Children's Research Hospital, Memphis, TN - 1/21/2016
• Statistical Exploration of How Multiple Enhancers Affect Traits Jointly. 
  Kyoto, Japan - 1/1/2016
• "Sickle Cell Disease: Advances in Therapy" 
  Memphis, TN - 1/16/2015
• "Coagulation: What the ABP Thinks You Should Know" 
  Memphis, TN - 1/7/2015
• "What is the Optimal Hydroxyurea Dosing?" 
  Atlanta, GA - 1/28/2014
• "Hope for Hydroxyurea" 
  Indianapolis, IN - 1/25/2014
• "Moving Forward in Sickle Cell Disease" 
  Memphis, TN - 1/17/2014
• "Infants with Sickle Cell Disease and Hydroxyurea" 
  Rio de Janeiro, Brazil - 1/10/2014
• "Pediatric Venous Thrombosis" 
  Memphis, TN - 1/8/2014
• Higher fetal hemoglobin in children treated with hydroxyurea at maximum tolerated dose provides additional clinical benefits. 
  San Francisco, CA - 1/1/2014
• "Sickle Cell Disease" 
  Memphis, TN - 1/10/2013
• Traumatic lumbar punctures in children receiving low-molecular-weight heparin during treatment for acute lymphoblastic leukemia or lymphoma. 
  Amsterdam, Netherlands - 1/1/2013
• "Cerebral Venous Sinus Thrombosis in Neuro-Oncology Patients" 
  St. Jude Children's Research Hospital, Memphis, TN - 1/10/2011
• "STOP I Trial-CVA in Sickle Cell Anemia" 
  St. Jude Children's Research Hospital, Memphis, TN - 1/1/2011
• "Intracranial Hemorrhage in Children with Hemophilia" 
  St. Jude Children's Research Hospital, Memphis, TN - 1/1/2011
• "Emergency Care Issues in Hemophilia" 
  St. Jude Children's Research Hospital, Memphis, TN - 1/20/2010
• "Hemostasis in Malignancy" 
  St. Jude Children's Research Hospital, Memphis, TN - 1/12/2010
• "Cerebral Venous Sinus Thrombosis and Leukemia: The Cross-Roads" 
  St. Jude Children's Research Hospital, Memphis, TN - 1/1/2009
• Join now to see all